Jesse Gibbs

Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3

D. Mutch, D. Piwnica-Worms, W. Hawkins, 2014, BMC Cancer.

Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption

R. Aurora, D. Novack, E. Shashkova, 2016, The Journal of Immunology.

This information is current as Regulate Bone Resorption To γ Induce T-bet , Eomesodermin , and IFN-CD 8 T Cells + Osteoclast-Primed Foxp 3 Novack and Rajeev Aurora

Déborah, E. Shashkova, Z. Buchwald, 2016 .

Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models

F. Gao, C. Sanchez, A. Lockhart, 2013, PloS one.

Manipulation of the Alternative NF‐κB Pathway in Mice Has Sexually Dimorphic Effects on Bone

R. Zeng, D. Veis, Jennifer L Davis, 2018, JBMR plus.

Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

R. Aurora, D. Novack, E. Shashkova, 2016, JCI insight.